Resveratrol Suppresses Cell Viability and Invasion in Pancreatic Cancer Cells

Year 2025, Volume: 6 Issue: 1, 22 - 27, 15.03.2025

Erhan Şahin

Abstract

Introduction: Pancreatic cancer is a challenging disease to diagnose and treat due to its asymptomatic progression and high mortality rate. It is often identified at an advanced stage, where it typically metastasizes to other organs. To address these challenges, scientific studies explore various treatments, including natural and anticancer compounds like resveratrol. This study investigates the effects of resveratrol on pancreatic cancer cells.

Methods: The study used PANC-1 pancreatic cancer cells cultured in vitro. Cell viability in resveratrol-containing media was measured using the MTT assay. Safe, toxic, and IC50 doses for a 24-hour period were determined. Morphological changes were analyzed using hematoxylin-eosin staining. In invasion experiments, a wound-healing assay was performed by scraping cells in a 6-well plate and photographing their movement in resveratrol media.

Results: Resveratrol increased cell viability at concentrations up to 10 µM, showed similar viability to the control at 50 µM, and reduced viability below 50% at 200 µM. The IC50 dose was calculated as 189.5 µM. At concentrations above 100 µM, significant disruptions in nuclear and cytoplasmic structures were observed. Additionally, cell movement ceased at 100, 150, and 189 µM doses, showing dose-dependent inhibition of cell invasion (p<0.05).

Conclusions: Resveratrol, a naturally occurring compound found in many fruits and plants, demonstrated cytotoxic and anti-metastatic effects on PANC-1 cells. This study highlights its potential role in pancreatic cancer treatment, emphasizing the importance of continued research to combat this aggressive disease effectively.

Keywords

PANC-1 cells, cell viability, anti-metastatic, resveratrol, anti-proliferative

Resveratrol, Pankreas Kanseri Hücrelerinde Hücre Canlılığını ve İnvazyonunu Baskılar

Abstract

Giriş: Pankreas kanseri, asemptomatik ilerlemesi, teşhis ve tedavisinin zor olması nedeniyle yüksek ölüm oranlarına neden olan bir hastalıktır. Genellikle ileri bir aşamada tanımlanır ve bu nedenle başka organlara metastaz yapar. Bu hastalığın tedavisindeki zorluklar nedeniyle araştırmacılar bazı antikanser özelliği yüksek moleküllerin de pankreas kanserine etkisini araştırmışlardır. Çalışmamızda, bu moleküllerden biri olan resveratrolün pankreas kanseri hücrelerine olan potansiyel etkilerini araştırdık.

Yöntemler: Çalışmamızda, in vitro kültüre edilmiş PANC-1 pankreas kanseri hücreleri kullanılmıştır. Resveratrol içeren midyumlarda hücre canlılığı, MTT testi kullanılarak ölçülmüştür. Resveratrolün 24 saatlik güvenli, sitotoksik ve IC50 dozları belirlenmiştir. Morfolojik değişiklikler hematoksilin-eozin boyama kullanılarak analiz edilmiştir. İnvazyon deneylerinde, 6 kuyucuklu plakalarda yara iyileştirme testi gerçekleştirilmiştir.

Bulgular: Resveratrol 10 µM'a kadar hücre canlılığını arttırmış, 50 µM'da kontrole benzer canlılık göstermiş ve 200 µM'da hücre canlılığını %50'nin altına düşürmüştür. IC50 dozu 189,5 µM olarak hesaplanmıştır. 100 µM'nin üzerindeki konsantrasyonlarda, nükleer ve sitoplazmik yapılarda önemli bozulmalar gözlenmiştir. Ek olarak, resveratrol hücre hareketini 100, 150 ve 189 µM’larda durdurarak hücre hareketinde doza bağlı inhibisyon göstermiştir (p<0,05).

Sonuç: Bu çalışma ile kanser proliferasyonunu ve hareketini inhibe edici etkiye sahip bir bileşikle pankreas kanseri tedavisine katkıda bulunma amaçlanmıştır. Birçok meyve ve bitkide bulunan ve doğal olarak oluşan bir bileşik olan resveratrol, PANC-1 hücreleri üzerinde sitotoksik ve anti-metastatik etkiler göstermiştir. Çalışmamız sonuçlarına göre, bu alanda daha fazla derinlemesine çalışmalara ihtiyaç olduğu açıktır.

Keywords

PANC-1 hücreleri, hücre canlılığı, anti-metastatik, resveratrol, anti-proliferatif

References

• Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. The Lancet 2016;388:73-85.
• Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. The Lancet 2020;395:2008-20.
• Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis. Int J Food Sci Nutr 2016;67:744-53.
• Hecht F, Zocchi M, Alimohammadi F, Harris IS. Regulation of antioxidants in cancer. Mol Cell 2024;84:23-33.
• Moar K, Brahma M, Kakde GS, Pant A, Maruthi M, Maurya PK. Protective Effect of Resveratrol Against Non-Small Cell Lung Cancer: In-Vitro and In-Silico Studies. Polycycl Aromat Compd 2024:1-16.
• Zhao X-Y, Zhong Q-H, Tan HW, et al. Non-cytotoxic levels of resveratrol enhance the anticancer effects of cisplatin by increasing the methyltransferase activity of CARM1 in human cancer cells. Phytomedicine 2024;135:156127.
• Jiang H, Wang GT, Wang Z, Ma QY, Ma ZH. Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts. World J Gastrointest Oncol 2024;16:3980-93.
• Xu Q, Zong L, Chen X, et al. Resveratrol in the treatment of pancreatic cancer. Ann N Y Acad Sci 2015;1348:10-19.
• Ribeiro E, Vale N. The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens. Targets 2024;2:307-26.
• Hu ZI, O’Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol 2024;21:7-24.
• Terzo M, Iantomasi M, Tsiani E. Effects of Resveratrol on Adipocytes: Evidence from In Vitro and In Vivo Studies. Molecules 2024;29.
• Brockmueller A, Sajeev A, Koklesova L, et al. Resveratrol as sensitizer in colorectal cancer plasticity. Cancer Metastasis Rev 2024;43:55-85.
• Zahra KF, Lefter R, Ali A, et al. The involvement of the oxidative stress status in cancer pathology: a double view on the role of the antioxidants. Oxidative Medicine and Cellular Longevity 2021;2021:9965916.
• Luo M, Zhou L, Huang Z, et al. Antioxidant therapy in cancer: rationale and progress. Antioxidants 2022;11:1128.
• Akan Z, Garip AI. Antioxidants may protect cancer cells from apoptosis signals and enhance cell viability. Asian Pacific Journal of Cancer Prevention 2013;14:4611-14.
• Cui J, Sun R, Yu Y, Gou S, Zhao G, Wang C. Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother Res 2010;24:1637-44.
• Liu P, Liang H, Xia Q, et al. Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression. Clin Transl Oncol 2013;15:741-46.
• Ding X-Z, Adrian TE. Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 2002;25:e71-e76.
• Ratajczak K, Glatzel-Plucińska N, Ratajczak-Wielgomas K, Nowińska K, Borska S. Effect of resveratrol treatment on human pancreatic cancer cells through alterations of Bcl-2 family members. Molecules 2021;26:6560.
• Xiao Y, Qin T, Sun L, et al. Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation. Cell Transplant 2020;29:1-14.
• Cao L, Chen X, Xiao X, Ma Q, Li W. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways. Int J Oncol 2016;49:735-43.